WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.

Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:

Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.

Click here to send you letter today.

More Articles

Mark’s PET Imaging Story

August 3, 2023

In March 2011, I was diagnosed with prostate cancer with a Gleason score of 7 (out of 10).…

Read More

Enhancing Patient Safety: An Insight into Medical Device Servicing Standards  

July 20, 2023

Wes Bonebright has over two decades of experience in the medical device servicing industry. As an engineer, Bonebright…

Read More

Patient Spotlight: Bobby Krause

July 13, 2023

Just a few years ago, Bobby was a 39-year-old marketing executive who reveled in the joys of parenthood,…

Read More

What You Need to Know About Breast Cancer Screening Guidelines

June 27, 2023

It’s alarming that breast cancer rates are on the rising among younger women.  While current guidance recommends mammograms…

Read More